Home › Bipolar Disorder › Arkansas
Pag-aaral pangklinika para sa Bipolar Disorder sa Arkansas
6 pag-aaral para sa Bipolar Disorder ang naghahanap ng mga kalahok sa mga site sa Arkansas.
Mga Lungsod sa Arkansas
Opisyal na teksto ng pag-aaral (English)
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Pillar Clinical Research, LLC, Little Rock
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Pillar Clinical Research, LLC, Little Rock
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06372964A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Sanro Clinical Research Group /ID# 279462, Bryant
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT06696755A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Pillar Clinical Research - Bentonville, Bentonville
- Pillar Clinical Research- Little Rock, Little Rock
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07140913Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.